Amendment of clause 13.2 (a) of the Omega Pharma SPAPERRIGO Co PLC • May 22nd, 2017 • Pharmaceutical preparations
Company FiledMay 22nd, 2017 IndustryReference is made to clause 13.2 (Non-compete and non-solicitation) of the sale and purchase agreement dated 6 November 2014 between Perrigo Company Plc (which assigned its rights and obligations to Perrigo Ireland 2 DAC), Holdco I BE NV and Alychlo NV, as amended per 27 April 2016, with respect to 95.77% of the shares in Omega Pharma Invest NV (the Omega Pharma SPA).
ContractPERRIGO Co PLC • May 22nd, 2017 • Pharmaceutical preparations • New York
Company FiledMay 22nd, 2017 Industry JurisdictionThis AMENDMENT NO. 3 (this “Amendment No. 3”), dated as of December 8, 2016 and entered into by and among Perrigo Finance Unlimited Company (formerly Perrigo Finance PLC), a public unlimited company organized under the laws of Ireland (the “Revolving Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Company”), certain Lenders listed on the signature pages hereto (the “Consenting Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), amends that certain Revolving Credit Agreement, dated as of December 5, 2014 (as amended by Amendment No. 1, dated as of February 26, 2016, as further amended by Amendment No. 2, dated September 9, 2016, and as further amended, restated, supplemented, waived or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), by and among the Revolving Borrower, the Company, the lenders party thereto, the Administrative Agent and
AgreementAgreement • May 22nd, 2017 • PERRIGO Co PLC • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2017 Company IndustryThis personal employment agreement (the “Agreement”) which was written and signed in Allegan, MI on the 25th day of the month of October year 2016
Amendment to the "Non-Compete Agreement Mr Coucke"Compete Agreement • May 22nd, 2017 • PERRIGO Co PLC • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2017 Company Industry
ContractPERRIGO Co PLC • May 22nd, 2017 • Pharmaceutical preparations • New York
Company FiledMay 22nd, 2017 Industry JurisdictionThis AMENDMENT NO. 3 (this “Amendment No. 3”), dated as of December 8, 2016 and entered into by and among Perrigo Finance Unlimited Company (formerly Perrigo Finance PLC), a public unlimited company organized under the laws of Ireland, Perrigo Company PLC, a public limited company organized under the laws of Ireland (together with Perrigo Finance Unlimited Company, the “Term Facility Borrowers”), certain Lenders listed on the signature pages hereto (the “Consenting Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), amends that certain Term Loan Credit Agreement, dated as of December 5, 2014 (as amended by Amendment No. 1, dated as of February 26, 2016, as further amended by Amendment No. 2, dated September 9, 2016, and as further amended, restated, supplemented, waived or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), by and among the Term Facility Borrowers, the lenders party thereto